Physician profile
Kendria Ward
NPI 1932362951
$521.47
in general payments reported to CMS, 2019-2025
10 companies · $69.74 in 2025
The $69.74 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.44 · 2021: $69.86 · 2022: $201 · 2023: $56.66 · 2024: $110 · 2025: $69.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $201.12 | 2022 | |
| Corium, LLC | $72.49 | 2024-2025 | Azstarys |
| Sobi, INC | $69.86 | 2021 | |
| Sanofi Pasteur INC. | $40.23 | 2023-2025 | |
| Glaxosmithkline, LLC. | $32.07 | 2020-2023 | Bexsero |
| Neurocrine Biosciences, INC. | $28.62 | 2024 | Ingrezza |
| Alk-Abello, INC | $23.31 | 2024 | Grastek, Odactra, Ragwitek |
| Merck Sharp & Dohme LLC | $20.66 | 2023 | Vaxelis, Vaxneuvance, Rotateq |
| Supernus Pharmaceuticals, INC. | $16.97 | 2024 | Qelbree |
| Neos Therapeutics, LP | $16.14 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendria Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.